Company Filing History:
Years Active: 2006-2012
Title: Jürgen Moll: Innovator in Kinase Inhibitors
Introduction
Jürgen Moll is a notable inventor based in Appiano Gentile, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of three patents to his name, his work is recognized for its potential impact on cancer treatment.
Latest Patents
Moll's latest patents include innovative compounds such as 1H-furo[3,2-C]pyrazole compounds, which are useful as kinase inhibitors. These compounds are designed to target diseases associated with disregulated protein kinase activity, specifically focusing on Aurora kinases and IGF-1R activity. Another significant patent involves pyrrolo[3,4-c]pyrazole derivatives, which also serve as kinase inhibitors and are aimed at treating similar conditions.
Career Highlights
Throughout his career, Jürgen Moll has worked with prominent companies in the pharmaceutical industry, including Pfizer Italia S.r.l. and Nerviano Medical Sciences S.r.l. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Moll has collaborated with several professionals in his field, including Daniele Fancelli and Barbara Forte. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Jürgen Moll's work in the field of kinase inhibitors showcases his dedication to advancing medical science. His innovative patents hold promise for the treatment of cancer and other diseases, highlighting the importance of research and collaboration in the pharmaceutical industry.